Bausch Health Companies Inc. Increase (Decrease) in Income Taxes Payable
Bausch Health Companies Inc. (BHC) reported Increase (Decrease) in Income Taxes Payable of $20.70 million for the 12-month period ending 2012-12-31, per its 10-K filed 2013-02-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable · last filed 2013-02-28
- Bausch Health Companies Inc. increase (decrease) in income taxes payable for the quarter ending 2012-12-31 was $34.56M.
- Bausch Health Companies Inc. increase (decrease) in income taxes payable for the quarter ending 2012-09-30 was -$311.00K, a 133.80% decline year-over-year.
- Bausch Health Companies Inc. increase (decrease) in income taxes payable for the quarter ending 2012-06-30 was -$15.12M.
- Bausch Health Companies Inc. increase (decrease) in income taxes payable for the quarter ending 2012-03-31 was $1.57M.
- Bausch Health Companies Inc. increase (decrease) in income taxes payable for fiscal 2012 was $20.70M.
- Bausch Health Companies Inc. increase (decrease) in income taxes payable for fiscal 2011 was -$15.50M.
- Bausch Health Companies Inc. increase (decrease) in income taxes payable for fiscal 2010 was -$9.72M, a 1439.26% decline from fiscal 2009.
- Bausch Health Companies Inc. increase (decrease) in income taxes payable for fiscal 2009 was $726.00K, a 91.66% decline from fiscal 2008.
| Period end | Increase (Decrease) in Income Taxes Payable 3 month | Increase (Decrease) in Income Taxes Payable 6 month | Increase (Decrease) in Income Taxes Payable 9 month | Increase (Decrease) in Income Taxes Payable 12 month |
|---|---|---|---|---|
| 2012-12-31 | $34.56M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $34.25M derived: sum of 2 quarters · filed 2013-02-28 | $19.13M derived: sum of 3 quarters · filed 2013-02-28 | $20.70M 10-K · filed 2013-02-28 |
| 2012-09-30 | -$311.00K 10-Q · filed 2012-11-05 | -$15.43M derived: sum of 2 quarters · filed 2012-11-05 | -$13.86M 10-Q · filed 2012-11-05 | -$15.68M derived: sum of 4 quarters · filed 2013-02-28 |
| 2012-06-30 | -$15.12M 10-Q · filed 2012-08-03 | -$13.55M 10-Q · filed 2012-08-03 | -$15.37M derived: sum of 3 quarters · filed 2013-02-28 | -$14.45M derived: sum of 4 quarters · filed 2013-02-28 |
| 2012-03-31 | $1.57M 10-Q · filed 2012-05-04 | -$249.00K derived: sum of 2 quarters · filed 2013-02-28 | $671.00K derived: sum of 3 quarters · filed 2013-02-28 | -$13.06M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-12-31 | -$1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | -$904.00K derived: sum of 2 quarters · filed 2013-02-28 | -$14.63M derived: sum of 3 quarters · filed 2013-02-28 | -$15.50M 10-K · filed 2013-02-28 |
| 2011-09-30 | $920.00K 10-Q · filed 2012-11-05 | -$12.81M derived: sum of 2 quarters · filed 2012-11-05 | -$13.67M 10-Q · filed 2012-11-05 | -$25.54M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-06-30 | -$13.73M 10-Q · filed 2012-08-03 | -$14.59M 10-Q · filed 2012-08-03 | -$26.46M derived: sum of 3 quarters · filed 2013-02-28 | -$29.39M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-03-31 | -$863.00K 10-Q · filed 2012-05-04 | -$12.73M derived: sum of 2 quarters · filed 2013-02-28 | -$15.66M derived: sum of 3 quarters · filed 2013-02-28 | -$11.99M derived: sum of 4 quarters · filed 2013-02-28 |
| 2010-12-31 | -$11.87M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | -$14.80M derived: sum of 2 quarters · filed 2013-02-28 | -$11.12M derived: sum of 3 quarters · filed 2013-02-28 | -$9.72M 10-K · filed 2013-02-28 |
| 2010-09-30 | -$2.93M 10-Q · filed 2011-11-04 | $747.00K derived: sum of 2 quarters · filed 2011-11-04 | $2.15M 10-Q · filed 2011-11-04 | $1.30M derived: sum of 4 quarters · filed 2012-02-29 |
| 2010-06-30 | $3.68M 10-Q · filed 2011-08-08 | $5.08M 10-Q · filed 2011-08-08 | $4.23M derived: sum of 3 quarters · filed 2012-02-29 | $5.11M derived: sum of 4 quarters · filed 2012-02-29 |
| 2010-03-31 | $1.40M 10-Q · filed 2011-05-10 | $551.00K derived: sum of 2 quarters · filed 2012-02-29 | $1.44M derived: sum of 3 quarters · filed 2012-02-29 | $1.12M derived: sum of 4 quarters · filed 2012-02-29 |
| 2009-12-31 | -$850.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | $36.00K derived: sum of 2 quarters · filed 2012-02-29 | -$284.00K derived: sum of 3 quarters · filed 2012-02-29 | $726.00K 10-K · filed 2012-02-29 |
| 2009-09-30 | $886.00K 10-Q · filed 2010-11-05 | $566.00K derived: sum of 2 quarters · filed 2010-11-05 | $1.58M 10-Q · filed 2010-11-05 | |
| 2009-06-30 | -$320.00K 10-Q · filed 2010-08-06 | $690.00K 10-Q · filed 2010-08-06 | ||
| 2008-12-31 | $8.70M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |